Layer 01
Consent
Adult-derived cells · approved programs · participant rights
The Engine
The CoreX Bio-Intelligence Engine.
CoreX combines four layers into one integrated engine, supporting defined programs in drug safety, dosing, pharmacokinetics, and population-specific response. Every biological asset should be traceable to consent, purpose, governance, and permitted use, and each application is developed within a defined context of use, not a broad universal claim.
The Engine Room
One governed path, from consent to insight.
Scroll through the engine. Each layer builds on the one before it, and every cycle adds to the evidence.
Layer 01
It starts with consent.
Every CoreX program begins with consented, adult-derived cells from relevant populations, each traceable to its consent, purpose, and permitted use.
Layer 02
Then living human biology.
Those cells become Bio-Avatars and organ-on-chip systems: living, donor-specific models that show how human tissue actually responds.
Layer 03
Then population variation.
Bio-Avatars are organized into governed cohorts, so biological response can be studied across selected population groups, not a single average.
Layer 04
Then governed AI.
Auditable models learn from biological response within defined contexts of use, turning signal into decision-support intelligence.
The result
Evidence that compounds.
Each governed cycle adds to a sovereign biological intelligence asset that becomes more valuable as evidence accumulates.
The CoreX Moat
Why this is hard to copy.
CoreX is not a single technology. It is four reinforcing layers that become more valuable together, and more valuable over time.
Living human biology
Bio-Avatars and organ-on-chip systems built from consenting human cells.
Population specificity
Regional cohorts and biological diversity, not a single average.
Governance infrastructure
Consent, ethics, sovereignty, and a secure research environment.
Compounding Bio-AI
Models that improve as governed biological response data accumulates.
Sovereign biological intelligence
Technology Lineage
CoreX and Quris-AI.
CoreX deploys proven Bio-AI and organ-on-chip capabilities from Quris-AI into sovereign, population-specific medicine programs.
Quris-AI develops the underlying Bio-AI clinical prediction platform. CoreX applies this platform within governed population cohorts, regional biological intelligence programs, and sovereign health-system partnerships.
The Foundation
Meet the Bio-Avatar.
A Bio-Avatar is a living, donor-specific model of selected biological systems.
From a single donor's cells, CoreX grows living models of their biology, heart, liver, kidney, blood-brain barrier and more, and connects them on one chip through a shared microfluidic channel. Exposed to a medicine, the models generate donor-specific biological response data, within defined contexts of use. This is the living foundation the engine is built on, before any AI.
What each organ does
Heart
Beats. Contracts in real time, so we can read how a medicine affects the heart.
Liver
Metabolises. Breaks compounds down, revealing toxicity and clearance.
Kidney
Filters. Clears compounds from the system and flags renal stress.
Blood-brain barrier
Gatekeeps. Models whether a compound can cross from blood into the brain.
This is where CoreX begins: not with generic data, but with living human biology.
From one person to a population
How It Works
From a consented cell to a population-adapted insight.
Most CoreX programs follow a governed path from consented biological sourcing to Bio-Avatar generation, organ-on-chip testing, biological response data, and AI-enabled interpretation.
01
Source
Consented adult-derived cells from relevant populations, each traceable to consent and governance.
02
Build
iPSC-derived Bio-Avatars and organ-on-chip systems that recreate how human tissue behaves.
03
Generate
Run medicines across the models to produce 3D human response data: toxicity, metabolism, and exposure.
04
Train
Governed Bio-AI learns drug-to-response patterns across individuals and population groups.
05
Interpret
Population-specific safety, dose, and exposure-response signals, so a medicine can be studied against the people who take it.
Proprietary organ modules
Liver organoid
Liver BioChip
iPSC Heart
Kidney-Chip
What a partner may receive: toxicity-risk signals, pharmacokinetic and dose-response profiles, exposure-response insights, and population-specific risk analysis, each delivered with documented methods, comparators, and limitations.